Back
Cosmo Pharmaceuticals NV 10K Form
Sell
18
CMOPF
Cosmo Pharmaceuticals NV
Last Price:
69.62
Seasonality Move:
10.19%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CMOPF News And Ratings
See the #1 stock for the next 7 days that we like better than CMOPF
CMOPF Financial Statistics
Sales & Book Value
| Annual Sales: | $100.44M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 10.64 |
| Annual Sales: | $33.30 |
| Price / Book: | 2.09 |
Profitability
| EPS (TTM): | 4.63750 |
|---|---|
| Net Income (TTM): | $74.91M |
| Gross Margin: | $80.05M |
| Return on Equity: | 15.06% |
| Return on Assets: | 10.72% |
Cosmo Pharmaceuticals NV Earnings Forecast
Key Cosmo Pharmaceuticals NV Financial Ratios
- The Gross Profit Margin over the past 20 years for CMOPF is 79.70%.
- The Selling, General & Administrative Expenses for CMOPF have been equal to 5.82% of Gross Profit Margin.
- The Research & Development expenses have been 21.15% of Revenue.
- The Interest Expense is -172.87% of Operating Income.
- The Net Earning history of CMOPF is -5.32% of Total Revenues.
- Per Share Earnings over the last 20 years have been positive in 11 years.
Cosmo Pharmaceuticals NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CMOPF |
| Website: | cosmopharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.85 |
| Quick Ratio: | 4.48 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CMOPF Technical Analysis vs Fundamental Analysis
Sell
18
Cosmo Pharmaceuticals NV (CMOPF)
is a Sell
Is Cosmo Pharmaceuticals NV a Buy or a Sell?
-
Cosmo Pharmaceuticals NV stock is rated a Sell
The current Cosmo Pharmaceuticals NV [CMOPF] share price is $69.62. The Score for CMOPF is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.